You are here: Industry Insights > Alembic Pharma

News List

Alembic Pharma gets USFDA nod for seizure treatment drug expresspharma
July 05, 2019
Alembic Pharmaceuticals said it has received approval from the US health regulator for Clonazepam orally disintegrating tablets, used for treatment of seizures.
Alembic Pharma gets US FDA nod for Oseltamivir Phosphate capsules expressbpd
June 27, 2019
The approved product is therapeutically equivalent to the reference listed drug (RLD), Tamiflu Capsules of Hoffman-La Roche
Alembic Pharma’s approves NCDs up to Rs 300 crore expressbpd
June 14, 2019
The company, which did not specify the reasons for raising funds, said it will issue NCDs in one or more tranches
Alembic Pharma gets USFDA nod for erectile dysfunction drug expressbpd
March 28, 2019
The approval from the USFDA, is for the company’s abbreviated new drug application (ANDA) for Tadalafil tablets USP, in the strengths of 2.5 mg, 5mg, 10mg and 20 mg.
Alembic Pharma gets US FDA nod for Parkinson’s treatment drug expressbpd
January 04, 2019
The approved product is a therapeutic equivalent to the reference listed drug product (RLD) Mirapex ER tablets, of Boehringer lngelheim Pharmaceuticals
Alembic Pharma gets US FDA nod for Xylocaine pain relief ointment expressbpd
November 26, 2018
Alembic Pharmaceuticals stated that its joint venture with Aleor Dermaceuticals has received approval from the US health regulator for Xylocaine ointment, used for temporary relief of pain associated with minor burns, including sunburn, abrasions of the s
Alembic Pharma posts net profit of Rs 93.79 cr in Q4 financialexpress
May 21, 2018
Drug firm Alembic Pharmaceuticals reported a consolidated net profit of Rs 93.79 crore for the quarter ended March 31, 2018.
Alembic Pharma gets US FDA nod for Acyclovir ointment expressbpd
April 10, 2018
The drug is used for management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients
Alembic Pharma sells formulations manufacturing facility to SEPL expressbpd
August 25, 2017
The company has sold its formulations manufacturing facility at Baddi on slump sale basis
Alembic Pharma opens Rs 300 cr facility in Vadodara financialexpress
July 17, 2017
With the new anti-cancer facility, the company will expand its presence in the growing global oncology segment

Previous page 1 2 3 Next page